24.10.2018 • News

PolyOne Opens new TPE Unit in India

PolyOne Opens new TPE Unit in India (c) Polyone
PolyOne Opens new TPE Unit in India (c) Polyone

US specialty polymers producer PolyOne has commissioned a new plant for thermoplastic elastomers (TPEs) at its complex in Pune, India. The new facility is complemented by a technology center, which will house an advanced laboratory for new and existing R&D activities.

The Ohio-based company said the highly automated and dedicated TPE line is the first of its kind in India. Adding the production facility also increases its global footprint for consistent material formulations in all regions, it said.

Producing locally rather than importing materials will improve lead times and the ability to collaborate on custom formulations, while the same time enabling manufacturers to source all of their specialty requirements from a single domestic source, the polymer producer commented.

In 2014, PolyOne opened a new production facility for colorant and additive concentrates at Pune, designed to supply end-markets such as transportation, electronics & electrical, healthcare, wire & cable, and packaging. Manufacturing capability for specialty engineered materials was added in 2017.

Holger Kronimus, vice president Europe at the materials company, said PolyOne is “committed to serving the needs of local and multinational manufacturers who operate in India, one of the world’s fastest growing economies.”

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read